Adaptive hypofractionated gamma knife radiosurgery in the acute management of large thymic carcinoma brain metastases

Background: Brain metastases often lead to serious neurological impairment and life threatening states. Their acute management remains complex, particularly in the case of rare malignancies with aggressive evolution. In large single lesions, open surgery followed by radiation to the surgical cavity is widely regarded as the best approach; yet in many cases, microsurgery is not feasible due to the lesion's critical location and/or the number of brain metastases present. We report the effects of adaptive hypofractionated gamma knife radiosurgery in the acute management of critically located thymic carcinoma metastases. Case Description: A 50-year-old male with metastatic thymic carcinoma was treated with radiosurgery for two large supratentorial brain metastases (M3 and M4) adjacent to eloquent areas and one smaller cerebellar metastasis (M2). M3 and M4 were treated with adaptive hypofractionated gamma knife radiosurgery, showing a dramatic volume reduction 4 weeks after treatment completion without radiation-induced side effects. Thirteen months later, two new small, threatening supratentorial lesions (M5-M6) were treated with the same technique. Interestingly, M2 (treated with standard single fraction) and M5-M6 developed local adverse radiation events. The patient's general and neurological status remained next to normal by the time of paper submission. Conclusion: The application of adaptive hypofractionated radiosurgery in this acute setting proved effective in terms of rapid tumor ablation, with salvage of neurological functionality and limited toxicity. We have called the overall procedure rapid rescue radiosurgery (RRR). A systematic study of past and ongoing RRR-treatments is warranted and in progress.

[1]  Jennifer S. Yu,et al.  Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases. , 2017, Journal of neurosurgery.

[2]  V. Esposito,et al.  Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis. , 2016, International journal of radiation oncology, biology, physics.

[3]  Luca Cozzi,et al.  Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection , 2016, Radiation Oncology.

[4]  G Vogin,et al.  Radionecrosis after stereotactic radiotherapy for brain metastases , 2016, Expert review of neurotherapeutics.

[5]  Y. Ejima,et al.  Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer , 2016, Strahlentherapie und Onkologie.

[6]  L. Lunsford,et al.  Gamma Knife Radiosurgery for 5 to 10 Brain Metastases: A Good Option for Upfront Treatment. , 2016, Oncology.

[7]  T. Kohno,et al.  Medical treatment involving investigational drugs and genetic profile of thymic carcinoma. , 2016, Lung cancer.

[8]  J. Bartek,et al.  Adaptive hypofractionated gamma knife radiosurgery for a large brainstem metastasis , 2016, Surgical neurology international.

[9]  David A. Larson,et al.  Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases , 2016, Oncotarget.

[10]  A. Akabane,et al.  Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment , 2015, PloS one.

[11]  D. Brenner,et al.  High-dose and fractionation effects in stereotactic radiation therapy: Analysis of tumor control data from 2965 patients. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  David Mathieu,et al.  Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. , 2014, Journal of neurosurgery.

[13]  John Y. K. Lee,et al.  Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. , 2014, Journal of neurosurgery.

[14]  T. Maehara,et al.  Clinical Benefit of 11C Methionine PET Imaging as a Planning Modality for Radiosurgery of Previously Irradiated Recurrent Brain Metastases , 2014, Clinical nuclear medicine.

[15]  L. Souhami,et al.  The Management of Brain Metastases in Non-Small Cell Lung Cancer , 2014, Front. Oncol..

[16]  A. Mishra,et al.  11C-MET PET/CT and Advanced MRI in the Evaluation of Tumor Recurrence in High-Grade Gliomas , 2014, Clinical nuclear medicine.

[17]  F. Venuta,et al.  Outcome of surgically resected thymic carcinoma: a multicenter experience. , 2014, Lung cancer.

[18]  Kocher,et al.  Stereotactic radiosurgery for treatment of brain metastases , 2014, Strahlentherapie und Onkologie.

[19]  A. Sahgal,et al.  Hypofractionated Stereotactic Radiotherapy in Five Daily Fractions for Post-Operative Surgical Cavities in Brain Metastases Patients with and without Prior Whole Brain Radiation , 2013, Technology in cancer research & treatment.

[20]  S. Deng,et al.  Detection of glioma recurrence by 11C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis , 2013, Nuclear medicine communications.

[21]  H. Shu,et al.  Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation , 2013, Radiation oncology.

[22]  P. Dartevelle,et al.  Thymic carcinomas: clinicopathologic study of 37 cases from a single institution , 2013, Virchows Archiv.

[23]  Nicholas F. Marko,et al.  Role of Gamma Knife surgery in patients with 5 or more brain metastases. , 2012, Journal of neurosurgery.

[24]  M. Bremer,et al.  Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach , 2012, BMC Cancer.

[25]  Cheng Yu,et al.  Early Decreased Tumor Volume Following Fractionated GammaKnife Radiosurgery for Metastatic Melanoma and the Role of “Adaptive Radiosurgery”: Case Report , 2010, Neurosurgery.

[26]  Da-peng Shi,et al.  Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging , 2010, Neuroradiology.

[27]  Angelina Bockelbrink,et al.  Stereotactic radiosurgery for the treatment of brain metastases. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  M R Segal,et al.  Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2008, American Journal of Neuroradiology.

[29]  C. Hodge,et al.  Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma. , 2008, Journal of neurosurgery.

[30]  Shigeaki Higashiyama,et al.  Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy , 2008, Journal of Nuclear Medicine.

[31]  M. Sather,et al.  Intracranial leptomeningeal metastasis from thymic carcinoma: case report and review. , 2007, Surgical neurology.

[32]  Toshinori Hirai,et al.  Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. , 2005, AJNR. American journal of neuroradiology.

[33]  L. Sekhon,et al.  Haemorrhagic brain metastasis from a thymic carcinoma , 2004, Journal of Clinical Neuroscience.

[34]  T. Kuroiwa,et al.  Thymic Carcinoma Presenting as Cranial Metastasis with Intradural and Extracranial Extension: Case Report , 2004, Neurosurgery.

[35]  K. Ohata,et al.  Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? , 2003, Journal of neurosurgery.

[36]  L. Tomazzoli,et al.  Multiple brain metastases from "lymphoepithelioma-like" thymic carcinoma: a combined stereotactic-radiosurgical approach. , 2001, Surgical neurology.

[37]  M. Kagawa,et al.  [Falx metastasis of thymic carcinoma: a case report and review of literature]. , 1993, No shinkei geka. Neurological surgery.

[38]  Eddie Barendsen,et al.  21 years of Biologically Effective Dose , 2022 .